# Cyltezo

NDC: 0597-0405
Generic name: adalimumab-adbm
Labeler / Manufacturer: Boehringer Ingelheim Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: KIT
Routes: —
Marketing started: 20230701

FDA application: BLA761058

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0597-0405"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0597-0405
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=115ea79b-7209-7f19-b35d-36ec0828fbf5